Influence of Food Patterns on Endothelial Biomarkers: A Systematic Review

Journal of Clinical Hypertension

Volumn 16, Issue 12, 2014, Pages 907-913

  Defagó, María Daniela ^a,b   Elorriaga, Natalia ^a   Irazola, Vilma Edith ^a   Rubinstein, Adolfo Luis ^a  

^a INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER;

ATHEROGENESIS; B LYMPHOCYTE; CARDIOVASCULAR RISK; DIETARY REFERENCE INTAKE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEEDING BEHAVIOR; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GENE CONTROL; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; INFLAMMATION; METABOLISM; RISK FACTOR; VASCULAR ENDOTHELIUM;

BIOMARKERS; ENDOTHELIUM, VASCULAR; FOOD HABITS; HUMANS; INFLAMMATION; RISK FACTORS;

EID: 84919631278     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12431     Document Type: Review

References (51)

1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260.
2. Pou SA, Niclis C, Eynard AR, Díaz Mdel P. Dietary patterns and risk of urinary tract tumors: a multilevel analysis of individuals in rural and urban contexts. Eur J Nutr. 2014;53:1247-1253.
3. Aballay LR, Eynard AR, Díaz Mdel P, et al. Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr Rev. 2013;71:168-179.
4. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J. 2010;31:642-648.
5. Abegunde DO, Mathers CD, Adam T, et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370:1929-1938.
6. Tzoulaki I, Siontis KC, Ioannidis JP. Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomized trials: meta-epidemiology study. BMJ. 2011;343:d6829.
7. EUROCISS Working Group. Coronary and cerebrovascular population-based registers in Europe: are morbidity indicators comparable? Results from the EUROCISS Project. Eur J Public Health. 2003;13(3 Suppl):S55-S60.
8. Hinderliter AL, Babyak MA, Sherwood A, Blumenthal JA. The DASH diet and insulin sensitivity. Curr Hypertens Rep. 2011;13:67-73.
9. Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood pressure. Annu Rev Nutr. 2010;30:365-401.
10. Pérez-Escamilla R. Acculturation, nutrition, and health disparities in Latinos. Am J Clin Nutr. 2011;93(Suppl):1163S-1167S.
11. Luca F, Perry GH, Di Rienzo A. Evolutionary adaptations to dietary changes. Annu Rev Nutr. 2010;30:291-314.
12. Tucker KL. Dietary patterns, approaches, and multicultural perspective. Appl Physiol Nutr Metab. 2010;35:211-218.
13. Taddei S, Salvetti A. Pathogenetic factors in hypertension. Endothelial factors. Clin Exp Hypertens. 1996;18:323-335.
14. Lurie A. Endothelial dysfunction in adults with obstructive sleep apnea. Adv Cardiol. 2011;46:139-170.
15. Thompson AM, Zhang Y, Tong W, et al. Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China. BMC Endocr Disord. 2011;11:11-16.
16. Defagó MD, Soria EA. Biomarker assessment in nutritional modulation of oxidative stress-induced cancer development by lipid-related bioactive molecules. Recent Pat Anticancer Drug Discov. 2010;5:188-196.
17. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep. 2010;12:135-142.
18. Calder PC, Ahluwalia N, Brouns F, et al. Dietary factors and low grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106(3 Suppl):S5-S78.
19. Ahluwalia N, Andreeva VA, Kesse-Guyot E, Hercberg S. Dietary patterns, inflammation and the metabolic syndrome. Diabetes Metab. 2013;39:99-110.
20. Oude Griep LM, Wang H, Chan Q. Empirically-derived dietary patterns, diet quality scores, and markers of inflammation and endothelial dysfunction. Curr Nutr Rep. 2013;2:97-104.
21. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;62:1-34.
22. Schulze MB, Hoffmann K, Kroke A, Boeing H. An approach to construct simplified measures of dietary patterns from exploratory factor analysis. Br J Nutr. 2003;89:409-418.
23. Panagiotakos DB, Pitsavos C, Skoumas Y, Stefanadis C. The association between food patterns and the metabolic syndrome using principal components analysis: The ATTICA Study. J Am Diet Assoc. 2007;107:979-987.
24. von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457.
25. Fung TT, Rimm EB, Spiegelman D, et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr. 2001;73:61-67.
26. Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004;80:1029-1035.
27. Nettleton JA, Steffen LM, Mayer-Davis EJ, et al. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2006;83:1369-1379.
28. Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr. 2007;137:992-998.
29. Nanri A, Yoshida D, Yamaji T, et al. Dietary patterns and C-reactive protein in Japanese men and women. Am J Clin Nutr. 2008;87:1488-1496.
30. Eilat-Adar S, Mete M, Nobmann ED, et al. Dietary patterns are linked to cardiovascular risk factors but not to inflammatory markers in Alaska Eskimos. J Nutr. 2009;139:2322-2328.
31. Hlebowicz J, Persson M, Gullberg B, et al. Food patterns, inflammation markers and incidence of cardiovascular disease: the Malmö Diet and Cancer study. J Intern Med. 2011;270:365-376.
32. Nanri H, Nakamura K, Hara M, et al. Association between dietary pattern and serum C-reactive protein in Japanese men and women. J Epidemiol. 2011;21:122-131.
33. Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13:3-9.
34. Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort. Circulation. 2006;113:195-202.
35. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473-2476.
36. Hagan G, Pepke-Zaba J. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds. Expert Rev Respir Med. 2011;5:163-171.
37. Lajemi M, Gautier S, Poirier O, et al. Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives. Am J Hypertens. 2001;14:755-760.
38. Zhang Y, Thompson AM, Tong W, et al. Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China. J Hypertens. 2010;28:35-40.
39. Reedy J, Wirfält E, Flood A, et al. Comparing 3 dietary pattern methods-cluster analysis, factor analysis, and index analysis-With colorectal cancer risk: The NIH-AARP Diet and Health Study. Am J Epidemiol. 2010;171:479-487.
40. Lozano-Nuevo JJ, Estrada-Garcia T, Vargas-Robles H, et al. Correlation between circulating adhesion molecules and resistin levels in hypertensive type-2 diabetic patients. Inflamm Allergy Drug Targets. 2011;10:27-31.
41. West NA, Crume TL, Maligie MA, Dabelea D. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia. 2011;54:504-507.
42. Fouillioux C, Contreras F, Lares M, et al. Metabolic and hemodynamic markers of endothelial dysfunction in patients with hypertension and patients with type 2 diabetes during the cold pressor test. Am J Ther. 2008;15:389-396.
43. Wahren J, Kallas A, Sima AA. The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes. 2012;61:761-772.
44. Barone Gibbs B, Dobrosielski DA, Bonekamp S, et al. A randomized trial of exercise for blood pressure reduction in type 2 diabetes: effect on flow-mediated dilation and circulating biomarkers of endothelial function. Atherosclerosis. 2012;224:446-453.
45. Lubomirova M, Tzoncheva A, Petrova J, Kiperova B. Homocystein and carotid atherosclerosis in chronic renal failure. Hippokratia. 2007;11:205-209.
46. Hoch AZ, Papanek P, Szabo A, et al. Folic acid supplementation improves vascular function in professional dancers with endothelial dysfunction. PM R. 2011;3:1005-1012.
47. McDermott MM, Liu K, Ferrucci L, et al. Relation of interleukin-6 and vascular cellular adhesion molecule-1 levels to functional decline in patients with lower extremity peripheral arterial disease. Am J Cardiol. 2011;107:1392-1398.
48. Lominadze D, Dean WL, Tyagi SC, Roberts AM. Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol (Oxf). 2010;198:1-13.
49. Wang X, Chai H, Wang Z, et al. Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2008;295:2399-2408.
50. Bekci TT, Kayrak M, Kiyici A, et al. The association among lipoprotein-associated phospholipase A2 levels, total antioxidant capacity and arousal in male patients with OSA. Int J Med Sci. 2011;8:369-376.
51. Pircher J, Merkle M, Wörnle M, et al. Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2. Arthritis Res Ther. 2012;14:R225.